Stock Research for CRIS

CRIS

Featured Broker: Ally Invest

Get the due diligence for another stock.

 

CRIS Stock Chart & Research Data

The CRIS chart settings shown below allow you to select time intervals of 1 min, 30 mins, an hour or by day - week - month. There is also the ability to change the CRIS chart style to candles, hollow candles, bars, lines or add various indicators. You can even add a symbol and compare history.


 


CRIS Due diligence Resources & Stock Charts

The CRIS stock resources shown below were gathered to cut back on time by allowing you to visit multiple sites at once. For your convenience each link clicked will open in a window. In addition to the individual links there is a button at the bottom that will allow you to open all the links at the same time. Note opening all links at once may not work with all browsers. Some browsers block multiple windows, to resolve this please allow that site to use pop-ups.

The Four Most Popular Resources

CNN View CRIS Detailed Price Forecast - CNN Money CNN View CRIS Detailed Summary - Google Finance
Yahoo View CRIS Detailed Summary - Yahoo! Finance Zacks View CRIS Stock Research & Analysis - Zacks.com


Stock Analysis

TradeIdeas View CRIS Trends & Analysis - Trade-Ideas Barrons View CRIS Major Holders - Barrons
NASDAQ View CRIS Call Transcripts - NASDAQ Seeking View CRIS Breaking News & Analysis - Seeking Alpha
Spotlight View CRIS Annual Report - CompanySpotlight.com OTC Report View CRIS OTC Short Report - OTCShortReport.com
TradeKing View CRIS Fundamentals - TradeKing Charts View CRIS SEC Filings - Bar Chart
WSJ View Historical Prices for CRIS - The WSJ Morningstar View Performance/Total Return for CRIS - Morningstar
MarketWatch View the Analyst Estimates for CRIS - MarketWatch CNBC View the Earnings History for CRIS - CNBC
StockMarketWatch View the CRIS Earnings - StockMarketWatch MacroAxis View CRIS Buy or Sell Recommendations - MacroAxis
Bullish View the CRIS Bullish Patterns - American Bulls Short Pains View CRIS Short Pain Metrics - ShortPainBot.com


Social Media Mentions

StockTwits View CRIS Stock Mentions - StockTwits PennyStocks View CRIS Stock Mentions - PennyStockTweets
Twitter View CRIS Stock Mentions - Twitter Invest Hub View CRIS Investment Forum News - Investor Hub
Yahoo View CRIS Stock Mentions - Yahoo! Message Board Seeking Alpha View CRIS Stock Mentions - Seeking Alpha






Financial & Transaction Holdings

SECform4 View Insider Transactions for CRIS - SECform4.com Insider Cow View Insider Transactions for CRIS - Insider Cow
CNBC View CRIS Major Holdings Summary - CNBC OTC Markets View Insider Disclosure for CRIS - OTC Markets
Yahoo View Insider Transactions for CRIS - Yahoo! Finance NASDAQ View Institutional Holdings for CRIS - NASDAQ


Stock Charts

FinViz View CRIS Stock Insight & Charts - FinViz.com StockCharts View CRIS Investment Charts - StockCharts.com
BarChart View CRIS Stock Overview & Charts - BarChart Trading View View CRIS User Generated Charts - Trading View


Latest Financial News for CRIS

Curis to Release First Quarter 2018 Financial Results and Hold Conference Call on May 3, 2018
Posted on Thursday April 26, 2018

LEXINGTON, Mass., April 26, 2018 /PRNewswire/ -- Curis, Inc. (CRIS), a biotechnology company focused on the development and commercialization of innovative and effective therapeutics for the treatment of cancer, today announced that the Company will release its first quarter 2018 financial results on Thursday, May 3, 2018, before the U.S. financial markets open. The Company's management will also host a conference call on the same day at 8:30 a.m. EDT. Curis is a biotechnology company focused on the development and commercialization of innovative and effective drug candidates for the treatment of human cancers, including CUDC-907, which is being investigated in clinical studies in patients with lymphomas and solid tumors.


Are Earnings Prospects Improving For Loss-Making Curis Inc’s (NASDAQ:CRIS)?
Posted on Friday April 20, 2018

Improvement in profitability and outperformance against the industry can be important characteristics in a stock for some investors. Below, I will assess Curis Inc’s (NASDAQ:CRIS) track record on a highRead More...


Free Post Earnings Research Report: Curis’ Quarterly Revenue Jumped 38.10%
Posted on Thursday April 19, 2018

Stock Monitor: Aldeyra Therapeutics Post Earnings Reporting LONDON, UK / ACCESSWIRE / April 19, 2018 / Active-Investors.com has just released a free earnings report on Curis, Inc. (NASDAQ: CRIS ). If you ...


Curis Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
Posted on Friday April 06, 2018

LEXINGTON, Mass., April 6, 2018 /PRNewswire/ -- Curis, Inc. (CRIS), a biotechnology company focused on the development and commercialization of innovative and effective drug candidates for the treatment of human cancers, today announced that on April 2, 2018, the independent Compensation Committee of the Board of Directors of Curis approved the grant of inducement stock options to purchase a total of 250,000 shares of Curis common stock to three new employees, with a grant date of April 2, 2018 (the "Q2 2018 Inducement Grants").


Enter a stock symbol to view the stock details.